Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC)

United Kingdom (UK)

1 April 2020 - 31 March 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC) published between 1 April 2020 - 31 March 2021 which are tracked by the Nature Index.

Research collaboration: Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC) is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count	Share
17	0.62

1 April 2020 - 31 March 2021

International vs. domestic collaboration by Share

61.43% Domestic
38.57% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (102 total)

Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC), United Kingdom (UK)
Domestic institution

University of Cambridge, United Kingdom (UK) (3.49)

0.62

2.86
University of Leeds, United Kingdom (UK) (3.32)

0.60

2.72
Leeds Institute of Medical Research at St James's (LIMR), University of Leeds, United Kingdom (UK) (2.40)

0.60

1.80
St James's University Hospital, United Kingdom (UK) (1.30)

0.60

0.70
Leeds Teaching Hospitals NHS Trust (LTHT), United Kingdom (UK) (0.95)

0.60

0.35
Experimental Cancer Medicine Centre (ECMC) Network, United Kingdom (UK) (0.93)

0.62

0.31
Newcastle University, United Kingdom (UK) (0.78)

0.03

0.75
Heriot-Watt University, United Kingdom (UK) (0.40)

0.01

0.39
Newcastle University Centre for Cancer, United Kingdom (UK) (0.34)

0.01

0.33
The Newcastle Upon Tyne Hospitals NHS Foundation Trust (NUTH), United Kingdom (UK) (0.33)

0.03

0.31

Top 10 international collaborators by Share (489 total)

Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC), United Kingdom (UK)
Foreign institution

Mayo Clinic, United States of America (USA) (0.87)

0.13

0.74
Duke-National University of Singapore (Duke-NUS), Singapore (0.38)

0

0.37
Harvard University, United States of America (USA) (0.34)

0.09

0.25
National University of Singapore (NUS), Singapore (0.32)

0

0.31
University of Rome Tor Vergata, Italy (0.28)

0.01

0.27
National Institutes of Health (NIH), United States of America (USA) (0.28)

0.02

0.26
Agency for Science, Technology and Research (A*STAR), Singapore (0.27)

0

0.27
Radboud University Nijmegen (RU), Netherlands (0.26)

0.01

0.25
University of California, San Diego (UC San Diego), United States of America (USA) (0.26)

0.06

0.19
Massachusetts Institute of Technology (MIT), United States of America (USA) (0.24)

0.07

0.16

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC)

Participating institutions

Cambridge Experimental Cancer Medicine Centre (Cambridge ECMC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.